Page last updated: 2024-10-29

iotrolan and Coracohumeral Impingement

iotrolan has been researched along with Coracohumeral Impingement in 2 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamakado, K1
Kreitner, KF1
Loew, R1
Runkel, M1
Zöllner, J1
Thelen, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparing Two Methods of Subacromial Space Injection - A Randomised Blinded Trial[NCT03692091]100 participants (Anticipated)Interventional2017-12-06Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for iotrolan and Coracohumeral Impingement

ArticleYear
The targeting accuracy of subacromial injection to the shoulder: an arthrographic evaluation.
    Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2002, Volume: 18, Issue:8

    Topics: Aged; Aged, 80 and over; Arthrography; Betamethasone; Contrast Media; Female; Humans; Injections, In

2002

Other Studies

1 other study available for iotrolan and Coracohumeral Impingement

ArticleYear
Low-field MR arthrography of the shoulder joint: technique, indications, and clinical results.
    European radiology, 2003, Volume: 13, Issue:2

    Topics: Arthrography; Contrast Media; Cost Control; Gadolinium DTPA; Humans; Image Enhancement; Image Proces

2003